Common Stock (Details Narrative) - USD ($) |
1 Months Ended | 6 Months Ended | |||||
|---|---|---|---|---|---|---|---|
Mar. 17, 2026 |
Feb. 27, 2026 |
Jun. 20, 2025 |
Mar. 19, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Common stock purchase | $ 5,000,000.0 | ||||||
| Proceeds from issuance of common stock | $ 1,440,000 | $ 15,000,000 | $ 16,440,000 | $ 0 | |||
| Common stock, shares issued | 6,250,000 | 26,305,966 | 19,455,966 | ||||
| Deferred offering costs | $ 0 | $ 481,250 | |||||
| Stock issued during period, shares, new issues | 600,000 | 937,500 | |||||
| Common stock offering price per share | $ 2.40 | ||||||
| Common stock, par value | $ 2.40 | $ 0.001 | $ 0.001 | ||||
| Description of stock option exercise | the Company issued (i) 63,796 shares of common stock to the Company’s Chief Executive Officer upon a cashless exercise of an option to purchase 100,000 shares of common stock at an exercise price of $0.95 per share, and (ii) 63,796 shares of common stock to the Company’s Senior Vice President and Chief Technology Officer upon a cashless exercise of an option to purchase 100,000 shares of common stock at an exercise price of $0.95 per share. Such share issuances were based upon a VWAP of $2.624 per share as determined under the terms of the options | ||||||
| Over-Allotment Option [Member] | |||||||
| Proceeds from issuance of common stock | $ 16,440,000 | ||||||
| Commissions and other offering expenses payable | $ 2,211,383 | ||||||